CombiMatrix Corporation Fund Company Profile

Description

CombiMatrix Corporation provides molecular diagnostic solutions and clinical support services. It offers DNA-based testing for the detection of genetic abnormalities. The company develops and markets its molecular testing services in the in vitro fertilization, miscarriage analysis, prenatal genetics, and postnatal developmental disorders markets. It provides its services primarily in the area of reproductive health for the diagnosis of developmental disorders associated with intellectual disability, congenital anomalies, dysmorphic features, and autism spectrum disorders. The company serves commercial insurance companies, healthcare institutions, government payors, and individuals. CombiMatrix Corporation was founded in 1995 and is headquartered in Irvine, California.